Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126352131 | 12635213 | 1 | I | 20160611 | 20160719 | 20160808 | 20160808 | EXP | US-PRESTIGE BRANDS -1056069 | PRESTIGE | 62.00 | YR | F | Y | 0.00000 | 20160808 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126352131 | 12635213 | 1 | PS | GOODYS | ACETAMINOPHENASPIRINCAFFEINE | 1 | Oral | Y | U | 999999 | 2 | DF | ORAL POWDER | ||||||
| 126352131 | 12635213 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126352131 | 12635213 | 1 | Headache |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126352131 | 12635213 | HO |
| 126352131 | 12635213 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126352131 | 12635213 | Abdominal pain upper | |
| 126352131 | 12635213 | Acute hepatic failure | |
| 126352131 | 12635213 | Adverse reaction | |
| 126352131 | 12635213 | Amnesia | |
| 126352131 | 12635213 | Back pain | |
| 126352131 | 12635213 | Dialysis | |
| 126352131 | 12635213 | Drug abuse | |
| 126352131 | 12635213 | Dysarthria | |
| 126352131 | 12635213 | Dyspnoea | |
| 126352131 | 12635213 | Headache | |
| 126352131 | 12635213 | Hypoacusis | |
| 126352131 | 12635213 | Loss of consciousness | |
| 126352131 | 12635213 | Malaise | |
| 126352131 | 12635213 | Oxygen saturation decreased | |
| 126352131 | 12635213 | Poisoning | |
| 126352131 | 12635213 | Renal failure | |
| 126352131 | 12635213 | Swelling | |
| 126352131 | 12635213 | Tremor | |
| 126352131 | 12635213 | Weight increased | |
| 126352131 | 12635213 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126352131 | 12635213 | 1 | 2006 | 201606 | 0 |